Covid-19: Monoclonal antibodies authorised in US as alternative to vaccines for certain groups
The US drug regulator has granted emergency use authorisation to a combination of two monoclonal antibodies to prevent covid-19 in adults and children over 12 who are immunocompromised and may not…
